BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22716190)

  • 1. Antibiotic lock solutions allow less systemic antibiotic exposure and less catheter malfunction without adversely affecting antimicrobial resistance patterns.
    Onder AM; Billings AA; Chandar J; Nield L; Francoeur D; Simon N; Abitbol C; Zilleruelo G
    Hemodial Int; 2013 Jan; 17(1):75-85. PubMed ID: 22716190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia.
    Onder AM; Chandar J; Simon N; Diaz R; Nwobi O; Abitbol CL; Zilleruelo G
    Nephrol Dial Transplant; 2008 Aug; 23(8):2604-10. PubMed ID: 18332071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of catheter-related bacteremia in pediatric intestinal transplantation/short gut syndrome children with long-term central venous catheters.
    Onder AM; Kato T; Simon N; Rivera-Hernandez M; Chandar J; Montane B; Francoeur D; Salvaggi G; Tzakis AG; Zilleruelo G
    Pediatr Transplant; 2007 Feb; 11(1):87-93. PubMed ID: 17239129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial locks: putting the lock on catheter infections.
    Manierski C; Besarab A
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):245-58. PubMed ID: 16815230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.
    Labriola L; Crott R; Jadoul M
    Nephrol Dial Transplant; 2008 May; 23(5):1666-72. PubMed ID: 18065789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.
    Onder AM; Chandar J; Simon N; Saint-Vil M; Francoeur D; Nwobi O; Abitbol C; Zilleruelo G
    Pediatr Nephrol; 2008 Mar; 23(3):457-64. PubMed ID: 18064496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
    Fernandez-Hidalgo N; Almirante B; Calleja R; Ruiz I; Planes AM; Rodriguez D; Pigrau C; Pahissa A
    J Antimicrob Chemother; 2006 Jun; 57(6):1172-80. PubMed ID: 16597634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter lock solutions to prevent bloodstream infections in high-risk hemodialysis patients.
    Feely T; Copley A; Bleyer AJ
    Am J Nephrol; 2007; 27(1):24-9. PubMed ID: 17215571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of dialysis catheter-related Enterococcus bacteremia with an antibiotic lock: a quality improvement report.
    Peterson WJ; Maya ID; Carlton D; Estrada E; Allon M
    Am J Kidney Dis; 2009 Jan; 53(1):107-11. PubMed ID: 18848379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
    Fortún J; Grill F; Martín-Dávila P; Blázquez J; Tato M; Sánchez-Corral J; García-San Miguel L; Moreno S
    J Antimicrob Chemother; 2006 Oct; 58(4):816-21. PubMed ID: 16899468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis.
    Onder AM; Chandar J; Coakley S; Abitbol C; Montane B; Zilleruelo G
    Pediatr Nephrol; 2006 Oct; 21(10):1452-8. PubMed ID: 16897007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia.
    Nori US; Manoharan A; Yee J; Besarab A
    Am J Kidney Dis; 2006 Oct; 48(4):596-605. PubMed ID: 16997056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution.
    Krishnasami Z; Carlton D; Bimbo L; Taylor ME; Balkovetz DF; Barker J; Allon M
    Kidney Int; 2002 Mar; 61(3):1136-42. PubMed ID: 11849468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic catheter locks in the treatment of tunneled hemodialysis catheter-related blood stream infection.
    Joshi AJ; Hart PD
    Semin Dial; 2013; 26(2):223-6. PubMed ID: 22856885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of preventing hemodialysis catheter infections with citrate lock.
    Silva J; Antunes J; Carvalho T; Ponce P
    Hemodial Int; 2012 Oct; 16(4):545-52. PubMed ID: 22515732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locks.
    Onder AM; Chandar J; Billings A; Simon N; Gonzalez J; Francoeur D; Abitbol C; Zilleruelo G
    Pediatr Nephrol; 2009 Nov; 24(11):2233-43. PubMed ID: 19590902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pros and cons of catheter lock solutions.
    Niyyar VD; Lok CE
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):669-74. PubMed ID: 24100219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PREFABL: predictors of failure of antibiotic locks for the treatment of catheter-related bacteraemia.
    Onder AM; Billings A; Chandar J; Francoeur D; Simon N; Abitbol C; Zilleruelo G
    Nephrol Dial Transplant; 2010 Nov; 25(11):3686-93. PubMed ID: 20501464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic lock: in vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37 degrees C.
    Battistella M; Vercaigne LM; Cote D; Lok CE
    Hemodial Int; 2010 Jul; 14(3):322-6. PubMed ID: 20345391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
    Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
    Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.